Bausch Health Cos (BHC) Competitors $6.72 -0.09 (-1.25%) Closing price 09/23/2025 03:59 PM EasternExtended Trading$6.75 +0.03 (+0.37%) As of 04:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BHC vs. MRNA, ELAN, VRNA, RVMD, GRFS, RYTM, LEGN, ABVX, RNA, and CYTKShould you be buying Bausch Health Cos stock or one of its competitors? The main competitors of Bausch Health Cos include Moderna (MRNA), Elanco Animal Health (ELAN), Verona Pharma PLC American Depositary Share (VRNA), Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Abivax (ABVX), Avidity Biosciences (RNA), and Cytokinetics (CYTK). These companies are all part of the "pharmaceutical products" industry. Bausch Health Cos vs. Its Competitors Moderna Elanco Animal Health Verona Pharma PLC American Depositary Share Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech Abivax Avidity Biosciences Cytokinetics Bausch Health Cos (NYSE:BHC) and Moderna (NASDAQ:MRNA) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, media sentiment, dividends, valuation and earnings. Does the media favor BHC or MRNA? In the previous week, Moderna had 12 more articles in the media than Bausch Health Cos. MarketBeat recorded 15 mentions for Moderna and 3 mentions for Bausch Health Cos. Bausch Health Cos' average media sentiment score of 0.76 beat Moderna's score of 0.57 indicating that Bausch Health Cos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bausch Health Cos 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Moderna 5 Very Positive mention(s) 3 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Positive Which has more risk and volatility, BHC or MRNA? Bausch Health Cos has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Comparatively, Moderna has a beta of 1.93, meaning that its share price is 93% more volatile than the S&P 500. Which has better earnings & valuation, BHC or MRNA? Bausch Health Cos has higher revenue and earnings than Moderna. Moderna is trading at a lower price-to-earnings ratio than Bausch Health Cos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBausch Health Cos$9.63B0.26-$46M$0.2625.87Moderna$3.24B3.10-$3.56B-$7.53-3.42 Do analysts recommend BHC or MRNA? Bausch Health Cos presently has a consensus target price of $9.00, indicating a potential upside of 33.83%. Moderna has a consensus target price of $41.81, indicating a potential upside of 62.13%. Given Moderna's stronger consensus rating and higher probable upside, analysts plainly believe Moderna is more favorable than Bausch Health Cos.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bausch Health Cos 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Moderna 4 Sell rating(s) 14 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.05 Is BHC or MRNA more profitable? Bausch Health Cos has a net margin of 0.99% compared to Moderna's net margin of -94.31%. Moderna's return on equity of -25.96% beat Bausch Health Cos' return on equity.Company Net Margins Return on Equity Return on Assets Bausch Health Cos0.99% -852.36% 5.25% Moderna -94.31%-25.96%-20.09% Do institutionals & insiders believe in BHC or MRNA? 78.7% of Bausch Health Cos shares are owned by institutional investors. Comparatively, 75.3% of Moderna shares are owned by institutional investors. 20.0% of Bausch Health Cos shares are owned by company insiders. Comparatively, 11.0% of Moderna shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryBausch Health Cos beats Moderna on 9 of the 17 factors compared between the two stocks. Get Bausch Health Cos News Delivered to You Automatically Sign up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BHC vs. The Competition Export to ExcelMetricBausch Health CosMED IndustryMedical SectorNYSE ExchangeMarket Cap$2.52B$4.31B$5.76B$21.71BDividend YieldN/A1.30%5.53%3.52%P/E Ratio25.8710.9776.0029.84Price / Sales0.2615.23472.9960.74Price / Cash0.887.1637.4624.72Price / Book-7.563.4213.374.59Net Income-$46M-$134.23M$3.29B$1.00B7 Day Performance-1.54%5.39%1.83%0.64%1 Month Performance-10.11%2.86%3.95%2.77%1 Year Performance-16.77%41.94%74.55%14.49% Bausch Health Cos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BHCBausch Health Cos4.612 of 5 stars$6.73-1.2%$9.00+33.8%-16.0%$2.52B$9.63B25.8720,700MRNAModerna4.4553 of 5 stars$26.56+5.2%$41.81+57.4%-59.8%$9.82B$3.24B0.005,800Trending NewsELANElanco Animal Health2.59 of 5 stars$19.08-0.6%$17.33-9.2%+28.5%$9.54B$4.44B22.199,000VRNAVerona Pharma PLC American Depositary Share2.0411 of 5 stars$106.25+0.2%$109.00+2.6%+259.0%$9.14B$42.28M-107.3230Positive NewsRVMDRevolution Medicines4.291 of 5 stars$44.41+2.0%$73.67+65.9%+3.7%$8.14B$11.58M0.00250GRFSGrifols3.9122 of 5 stars$9.70-0.4%$10.30+6.2%+11.9%$6.70B$7.81B8.2923,822RYTMRhythm Pharmaceuticals3.206 of 5 stars$99.00+3.1%$101.57+2.6%+93.3%$6.38B$130.13M-32.89140Positive NewsLEGNLegend Biotech3.1544 of 5 stars$34.08+0.2%$74.22+117.8%-28.3%$6.28B$627.24M0.002,609Positive NewsABVXAbivax2.8083 of 5 stars$82.21-0.1%$99.43+20.9%+655.2%$6.22BN/A0.0061RNAAvidity Biosciences2.0511 of 5 stars$42.34+3.1%$68.32+61.4%-2.8%$5.99B$10.90M-11.89190Analyst ForecastCYTKCytokinetics4.2414 of 5 stars$48.25-0.8%$75.71+56.9%-6.8%$5.82B$18.47M-9.46250Trending NewsAnalyst Forecast Related Companies and Tools Related Companies Moderna Alternatives Elanco Animal Health Alternatives Verona Pharma PLC American Depositary Share Alternatives Revolution Medicines Alternatives Grifols Alternatives Rhythm Pharmaceuticals Alternatives Legend Biotech Alternatives Abivax Alternatives Avidity Biosciences Alternatives Cytokinetics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BHC) was last updated on 9/24/2025 by MarketBeat.com Staff From Our PartnersWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredWarren Buffett’s #1 AI Stock: Not Mag 7, And NOT on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredIs This Nvidia’s Next Big Invention? (Picture Inside)Nvidia gave investors a chance to make more than 150 times their money with its AI chips known as graphic proc...InvestorPlace | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Cos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Cos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BHC Stock Alerts